The contribution of anti-Xa and anti-IIa activities to the profibrinolytic activity of low-molecular-weight heparins

被引：9
|
作者：
Ammollo, Concetta T. [1 ]
Semeraro, Fabrizio [1 ]
Semeraro, Nicola [1 ]
Colucci, Mario [1 ]
机构：
[1] Univ Bari, Dept Biomed Sci & Human Oncol, Sect Gen & Expt Pathol, Bari, Italy
来源：
THROMBOSIS AND HAEMOSTASIS | 2009年 / 101卷 / 04期
关键词：
THROMBIN; FIBRINOLYSIS; INHIBITORS;
D O I：
10.1160/TH08-09-0617
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：782 / 785
页数：4
相关论文
共 50 条
  • [1] Encapsulation of low molecular weight heparins: Influence on the anti-Xa/anti-IIa ratio
    Javot, L.
    Lecompte, T.
    Rabiskova, M.
    Maincent, P.
    JOURNAL OF CONTROLLED RELEASE, 2009, 139 (01) : 8 - 14
  • [2] ANTI-IIA AND ANTI-XA PLASMA ACTIVITIES AFTER SUBCUTANEOUS LOW-DOSE APPLICATION OF LOW-MOLECULAR-WEIGHT HEPARINS TO RABBITS
    HARBAUER, G
    KETTENRING, P
    HAEMOSTASIS, 1988, 18 : 64 - 68
  • [3] INVITRO EFFECT ON HEPTEST OF LOW-MOLECULAR-WEIGHT HEPARIN FRACTIONS AND PREPARATIONS WITH VARIOUS ANTI-IIA AND ANTI-XA ACTIVITIES
    BARA, L
    MARDIGUIAN, J
    SAMAMA, M
    THROMBOSIS RESEARCH, 1990, 57 (04) : 585 - 592
  • [4] THE EFFECT OF PLASMA-PROTEINS ON THE ANTI-IIA AND ANTI-XA ACTIVITIES OF STANDARD HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN
    COSMI, B
    WEITZ, JI
    HIRSH, J
    CIRCULATION, 1992, 86 (04) : 869 - 869
  • [5] Oral administration of a microencapsulated low-molecular-weight heparin to rabbits: Anti-Xa and anti-IIa profiles
    Javot, Lucie
    Sapin, Anne
    Scala-Bertola, Julien
    Vigneron, Claude
    Lecompte, Thomas
    Maincent, Philippe
    THROMBOSIS AND HAEMOSTASIS, 2010, 103 (06) : 1254 - 1267
  • [6] OPTIMIZATION OF A CLOT BASED ANTI-XA - ANTI-IIA METHOD FOR THE MONITORING OF SUBCUTANEOUS ADMINISTERED LOW-MOLECULAR WEIGHT HEPARINS
    AHSAN, A
    HOPPENSTEADT, D
    WALENGA, J
    BREDDIN, K
    FAREED, J
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 431 - 431
  • [7] Aging and venous thromboembolism influence the pharmacodynamics of the Anti-Xa and Anti-IIa activities of a low molecular weight heparin (Nadroparin)
    Boneu, B
    Mismetti, P
    Laporte, S
    Navarro, C
    Sie, P
    DAzemar, P
    Necciari, J
    Duret, JP
    Gaud, C
    Decousus, H
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1149 - P1149
  • [8] Routine Plasma Anti-Xa Monitoring is Required for Low-Molecular-Weight Heparins
    Hesham S. Al-Sallami
    Michael A. Barras
    Bruce Green
    Stephen B. Duffull
    Clinical Pharmacokinetics, 2010, 49 : 567 - 571
  • [9] Routine Plasma Anti-Xa Monitoring is Required for Low-Molecular-Weight Heparins
    Al-Sallami, Hesham S.
    Barras, Michael A.
    Green, Bruce
    Duffull, Stephen B.
    CLINICAL PHARMACOKINETICS, 2010, 49 (09) : 567 - 571
  • [10] RELATION BETWEEN ANTI-XA AND ANTI-IIA AMIDOLYTIC ACTIVITIES AND APTT PROLONGATION OF 3 LOW-MOLECULAR-WEIGHT HEPARIN FRACTIONS VERSUS UNFRACTIONATED HEPARIN
    SAMAMA, MM
    VANDREDEN, P
    QUENTIN, G
    ROLAND, N
    COMBOT, C
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 969 - 969
12345